Evidence map›Paper›PMID 42825937›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Correction to: Prevalence of meeting aerobic physical activity and resistance training guidelines in advanced prostate cancer: a descriptive study of racial and regional disparities in the IRONMAN registry.

Aleksander Solberg, May Grydeland, Tormod S Nilsen, Anne H Storås, Ian D Davis, Natalie Greaves, Simon Anderson, Andre P Fay, Kim N Chi, Deborah Enting and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Aleksander SolbergDepartment of Physical Performance, The Norwegian School of Sport Sciences, Oslo, Norway. aleksandso@nih.no.
May GrydelandDepartment of Physical Performance, The Norwegian School of Sport Sciences, Oslo, Norway.
Tormod S NilsenDepartment of Physical Performance, The Norwegian School of Sport Sciences, Oslo, Norway.
Anne H StoråsDepartment of Oncology, Oslo University Hospital, Oslo, Norway.
Ian D DavisEastern Health Clinical School, Monash University, Melbourne, Australia.
Natalie GreavesGeorge Alleyne Chronic Disease Research Centre, The University of the West Indies, Cave Hill Campus, Bridgetown, Barbados.
Simon AndersonGeorge Alleyne Chronic Disease Research Centre, The University of the West Indies, Cave Hill Campus, Bridgetown, Barbados.
Andre P FayPUCRS School of Medicine, Hospital Nora Teixeira, Santa Casa de Porto Alegre, Porto Alegre, Brazil.
Kim N ChiBC Cancer, Vancouver Prostate Centre, Department of Medicine, University of British Columbia, Vancouver, Canada.
Deborah EntingDepartment of Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Raymond McDermottSt. Vincent's University Hospital & Cancer Trials, Dublin, Ireland.
Simone BadalAfrican Caribbean Cancer Consortium, Philadelphia, USA.
Charles G WaihenyaAfrican Caribbean Cancer Consortium, Philadelphia, USA.
Ademola PopoolaDepartment of Urology, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
John M LazarusDepartment of Urology, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Joaquin MateoVall d'Hebron Institute of Oncology, Barcelona, Spain.
Anders BjartellDepartment of Translational Medicine (Urology), Skåne University Hospital, Lund University, Lund, Sweden.
Aurelius OmlinOnkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland.
Folakemi OdedinaMayo Clinic Florida, Jacksonville, Florida, USA.
Camille RaginAfrican Caribbean Cancer Consortium, Philadelphia, USA.
Lorelei A MucciDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
IRONMAN investigators
Kjell M RussnesDepartment of Oncology, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42825937
PMCPMC13633367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.